Streetbeat News

Products Services

DVA

DaVita Inc. has issued a statement in response to Novo Nordisk's FLOW study on Ozempic, a drug for type 2 diabetes, which aims to show that it delays the progression of chronic kidney disease (CKD) and lowers the risk of kidney and cardiovascular mortality. DaVita's chief medical officer, Dr. Jeff Giullian, stated that while it's too early to draw conclusions from the study, they believe its findings may have limited application to the overall CKD patient population. Novo Nordisk plans to release the FLOW study in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:36 pm

DSS

PRPH

DSS, Inc. has issued a letter to shareholders providing an update on the company's progress and future expectations. The company is preparing for an IPO of its majority-owned subsidiary, Impact Biomedical, Inc. (IBIO). DSS's product packaging division, Premier Packaging Corporation, Inc., reported a 27% increase in revenue for the first half of 2023. DSS Wealth Management, Inc. has enhanced its management team and plans to launch a Total Return Bond Fund. The company also plans to introduce shareholders to subsequent spinoffs or similar liquidity events after the Impact Biomedical IPO.

Portfolio Pulse from Happy Mohamed

October 12, 2023 | 12:28 pm

AAPL

META

Fitness app developer Andre Elijah has filed a lawsuit against Meta Platforms Inc. (NASDAQ:META) alleging that his AEI Fitness app project was abruptly canceled just days before its scheduled launch. Elijah is seeking $3.2 million in immediate damages and hundreds of millions more in lost revenue. The lawsuit also names Zuckerberg and Alo, a Beverly Hills fitness apparel and accessories company, as defendants. This lawsuit comes at a time when competition in the VR headset market is intensifying, with Apple Inc. (NASDAQ:AAPL) set to launch its Apple Vision Pro for sale in early 2024.

Portfolio Pulse from Benzinga Neuro

October 12, 2023 | 12:16 pm

ENPH

Enphase Energy, Inc. (NASDAQ:ENPH) has announced its entry into the South African solar market with the introduction of IQ8 Microinverters for grid-tied residential and small commercial applications. The move comes at a time when solar energy in South Africa is experiencing significant growth, with installed rooftop solar capacity increasing by 349% in just over a year. The IQ8 Microinverters are designed to maximize energy production and support higher powered solar modules. The company's products are now available for order in South Africa.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:09 pm

MEDS

TRxADE Health's subsidiary, Superlatus PD Holding Company, has entered into a supplier agreement with Rainforest Distribution Corp. The partnership will allow Superlatus to introduce its products to over 5,000 retail locations, including Whole Foods, Kroger, and more. The collaboration is expected to provide revenue growth and expansion opportunities for Superlatus's Consumer Package Goods portfolio.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:09 pm

ONTX

Onconova Therapeutics, Inc. (NASDAQ:ONTX) announced that a late-breaking abstract studying rigosertib in patients with recessive dystrophic epidermolysis bullosa (RDEB), associated with advanced/metastatic squamous cell carcinoma (SCC), will be presented at the European Academy of Dermatology and Venereology (EADV). The abstract outlines promising results from a study of four patients treated with rigosertib. Two patients achieved complete cutaneous responses of 12 months or more, one patient experienced metastatic disease progression, and one patient remains on study.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:09 pm

VRPX

Virpax Pharmaceuticals has extended its cooperative research and development agreement with the US Army Institute of Surgical Research. The extension will allow for continued collaboration on the development of non-opioid pain management solutions.

Portfolio Pulse from Bill Haddad

October 12, 2023 | 12:08 pm

AMRX

Amneal Pharmaceuticals has announced the addition of two Denosumab biosimilars referencing both Prolia and Xgeva to its biosimilar pipeline, thereby expanding its oncology portfolio.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:07 pm

NTAP

NetApp, a global cloud-led, data-centric software company, has renewed its partnership with Ducati Corse for the 2023 to 2025 seasons and has been named the team's Official Data Infrastructure Partner. The partnership has resulted in a virtual data management and insights solution for race analytics and R&D that uses NetApp ONTAP with NetApp SnapMirror and NetApp FlexCache. The solution provides near real-time data sharing and analytics, which can significantly impact race outcomes.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:06 pm

ANVS

Annovis Bio Inc. has announced that the interim analysis of their Alzheimer's Disease (AD) trial, based on 107 patients at 6 weeks, has shown positive results. The trial will continue as planned with the same size to maintain the statistical power for both co-primary endpoints.

Portfolio Pulse from Bill Haddad

October 12, 2023 | 12:06 pm